Westbourne Investment Advisors Inc. Increases Holding in CVS Health Corporation (CVS)

Lloyd Doyle
April 19, 2018

Following the sale, the executive vice president now owns 65,072 shares of the company's stock, valued at $4,622,714.88. Analysts mean recommendation for the stock is 2.00.

In total 14 analysts cover CVS Health (NYSE:CVS). There are advantages to using a moving average in your trading, as well options on what type of moving average to use.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Thursday, February 8th. CVS underperformed by 34.36% the S&P 500.

Dreyfus Municipal Bond Infrastructure Fund Inc (DMB) investors sentiment increased to 3.43 in 2017 Q4. It has change of 0.16, from 2017Q3's 0.88. On Thursday, January 4 the stock rating was maintained by SunTrust with "Buy".

Looking about the past performance history, the company plunged -1.88% for the last five trades and exhausted -8.61% in one month period. Sold All: 66 Reduced: 356 Increased: 349 New Position: 101. The company rating was maintained by Leerink Swann on Tuesday, November 7. Therefore 29% are positive. CVS Health had 73 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has a market capitalization of $84.05 billion, a P/E ratio of 16.89 and a beta of 0.84. The stock has been moved at -15.11 percent over the last six months and -18.94 percent during a year ago. The rating was downgraded by Goldman Sachs on Thursday, December 17 to "Neutral". As per Friday, October 27, the company rating was maintained by Robert W. Baird. Finally, Mizuho set a $95.00 price objective on shares of CVS Health and gave the company a "buy" rating in a research note on Wednesday, January 24th. RBC Capital Markets maintained CVS Health Corporation (NYSE:CVS) on Monday, December 4 with "Buy" rating. Rosenblatt initiated the stock with "Buy" rating in Wednesday, September 9 report. The firm has "Buy" rating given on Tuesday, June 13 by Cowen & Co. Investors of record on Monday, April 23rd will be paid a $0.50 dividend. Its down 0.16, from 0.88 in 2017Q3. It is negative, as 115 investors sold CVS shares while 600 reduced holdings.

Other hedge funds also recently added to or reduced their stakes in the company. To make a proper assessment, investors seek a sound estimate of this year's and next year's earnings per share (EPS), as well as a strong sense of how much the company will earn even farther down the road.

"Today's consumers are faced with higher prescription drug prices than ever before and many of them are now paying for a larger share of their prescription drug costs out of their own pockets at the pharmacy counter due to growth in high deductible health plans", Moriarty said. The institutional investor held 220,456 shares of the computer manufacturing company at the end of 2017Q4, valued at $37.31 million, up from 118,365 at the end of the previous reported quarter.

Sprint Corp. was down 0.33% and T-Mobile US Inc. declined 0.33% following a report from The Wall Street Journal that said the telecommunications giants have restarted merger talks. Vaughan David Invs Il holds 10,202 shares or 0.08% of its portfolio. Schroder Investment Mngmt Group reported 0.27% in CVS Health Corporation (NYSE:CVS).

While CVS Health's pharmacy benefit manager is facing accusations of keeping prescription spread pricing profits, the company has announced that it has held drug price inflation almost flat for its pharmacy benefit management clients. 136,665 were reported by Mcdaniel Terry &. Art Lc reported 93,000 shares. Bremer Tru Association stated it has 19,350 shares. About 20.21 million shares traded. (NYSE:T). California-based Perigon Wealth Ltd Liability Company has invested 0.11% in AT&T Inc.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. Mechanics Financial Bank Trust Department has 53,124 shares for 0.87% of their portfolio. Valley National Advisers Inc. now owns 1,790 shares of the pharmacy operator's stock valued at $171,000 after buying an additional 9 shares in the last quarter. Bnp Paribas Sa (Adr) (BNPQY) was raised too. Clifford Swan Investment Counsel LLC's holdings in CVS Health were worth $680,000 at the end of the most recent reporting period. Analyst established EPS growth expected to grow of 31.70% for this year and EPS growth for next year is likely to attain at 7.54%. GE's profit will be $1.04B for 27.17 P/E if the $0.12 EPS becomes a reality.

The stock increased 0.86% or $0.71 during the last trading session, reaching $83.45. The TJX Companies, Inc. Apple Inc. (NASDAQ:AAPL) has risen 19.49% since April 12, 2017 and is uptrending. It has underperformed by 8.88% the S&P500.

Bluespruce Investments Lp holds 11.11% of its portfolio in The TJX Companies, Inc. for 769,160 shares.

Veritas Asset Management Llp manages about $12.87B US Long portfolio. Banks shares gained as well, with J.P. Morgan Chase, Citigroup and Goldman Sachs all climbing more than 2 percent.

Other reports by Iphone Fresh

Discuss This Article